Patient Selection for Therapy Reduction after Long-Term Daily Proton Pump Inhibitor Treatment for Gastro-Oesophageal Reflux Disease: Trial and Error

Publisher： Karger

E-ISSN： 1421-9867|87|2|85-90

ISSN： 0012-2823

Source： Digestion, Vol.87, Iss.2, 2013-01, pp. : 85-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Managing Gastro-Oesophageal Reflux Disease in the Older Patient

By  

Digestion, Vol. 69, Iss. 1, 2004-03 ,pp. : 17-24

Karger

Access to resources Recommend Favorite

Gastro-Oesophageal Reflux Disease

By  

Digestion, Vol. 59, Iss. 5, 1998-08 ,pp. : 433-445

Karger

Access to resources Recommend Favorite

EndoCinch® Treatment for Gastro-Oesophageal Reflux Disease

By  

Digestion, Vol. 76, Iss. 3-4, 2008-01 ,pp. : 241-247

Karger

Access to resources Recommend Favorite

High-dose Proton-Pump Inhibitors as a Diagnostic Test of Gastro-oesophageal Reflux Disease in Endoscopic-negative Patients

By Juul-Hansen P.   Rydning A.   Jacobsen C. Ditlef   Hansen T.  

Scandinavian Journal of Gastroenterology, Vol. 36, Iss. 8, 2001-08 ,pp. : 806-810

Informa Healthcare

Access to resources Recommend Favorite

Impact of Comorbid Irritable Bowel Syndrome on Treatment Outcome in Non-Erosive Reflux Disease on Long-Term Proton Pump Inhibitor in Japan

By  

Digestion, Vol. 96, Iss. 1, 2017-06 ,pp. : 39-45

Karger

Access to resources Recommend Favorite